Ariel Precision Medicine
Dr. Whitcomb is a pioneer in the use of mathematics, genetics, genomics, cell biology, neurosciences, immunology and epidemiology to study complex inflammatory disorders and cancer risks of the digestive system. He co-founded Ariel Precision Medicine along with Jessica M. Gibson in 2015. As CSO, Dr. Whitcomb will utilize his experience and insights as a physician, scientist and innovator to oversee the scientific and translational functions of the company.